I'm too brain fogged to extrapolate right now, but I think that both @
heapsreal and @
DanielBR are right in talking about EBV as a triggering, or shall I say tipping factor, in a group of PWME.
They are right when they talk about the important study of Dr. Scheibenbogen at Charite in Berlin as well as the interest of Dr. Kogelnik here in the US to conduct a 4 arm study with both Valganciclovir and Rituximab (25% would get Rituxan only, 25% Rituxan+Valcyte, 25% Valcyte only and the remaining 25% placebo).
Ideally in the not too far future we'll also have Ampligen approved specifically for ME, but that is another long and twisted saga.
I hope to be alive and kicking to see all this treatments approved for ME.
The way I see this disease, that I've been living with for 3/4 of my life, is that it's a very serious neuro-immune disease that we are only now starting to pay attention to and because of the lagging of scientific interest in it we still don't see the forest, but the single trees. What I mean by saying that is that there might be subgroups, but we need to realize that being ME a chronic disease, just like lupus or MS, it's a continuum and we get to seek medical attention, when we can, at different times in the disease.
Our doctors have to realize that whatever organic damage we are now able to see (via MRI's etc.) it's only the tip of the iceberg.
I'm certain that my ME started with IM infectious mono (back in 1981) and then slowly took hold of my immune system, or dismantled whatever was left of it.
I got diagnosed only in 2011 and the window of opportunity for some treatments might be long gone.
This is just my personal story, but one that I've learned to recognize and share with many of my fellow sufferers.